Effects of training and albuterol on pain and fatigue in facioscapulohumeral muscular dystrophy

Journal of Neurology

Volumn 254, Issue 7, 2007, Pages 931-940

  Van Der Kooi, E L ^a   Kalkman, J S ^a   Lindeman, E ^b   Hendriks, J C M ^a   Van Engelen, B G M ^a   Bleijenberg, G ^a   Padberg, G W ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Albuterol; Exercise therapy; Facioscapulohumeral muscular dystrophy; Fatigue; Pain

Indexed keywords

PLACEBO; SALBUTAMOL;

ADULT; ANKLE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISTRESS SYNDROME; DOUBLE BLIND PROCEDURE; ELBOW FLEXION; FEMALE; FUNCTIONAL STATUS; HUMAN; KINESIOTHERAPY; MALE; MUSCLE FATIGUE; MUSCLE TRAINING; MUSCULAR DYSTROPHY; MYALGIA; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SHOULDER; SUSTAINED RELEASE FORMULATION; TREATMENT OUTCOME;

ADRENERGIC BETA-AGONISTS; ADULT; ALBUTEROL; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; EXERCISE; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE STRENGTH; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; PAIN; PAIN MEASUREMENT; PHYSICAL FITNESS; SICKNESS IMPACT PROFILE; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 34547700326     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-006-0432-4     Document Type: Article

References (43)

1. Aitkens SG, McCrory MA, Kilmer DD, Bernauer EM (1993) Moderate resistance exercise program: its effect in slowly progressive neuromuscular disease. Arch Phys Med Rehabil 74:711-715
2. American College of Sports Medicine Position Stand (1998) The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults. Med Sci Sports Exerc 30:975-991
3. American College of Sports Medicine Position Stand (2002) Progression models in resistance training for healthy adults. Med Sci Sports Exerc 34:364-380
4. Arahata K, Ishihara T, Fukunaga H, et al. (1995) Inflammatory response in facioscapulohumeral dystrophy (FSHD): immunocytochemical and genetic analysis. Muscle Nerve 2:S56-S66
5. Arindell WA, Ettema JHM (1986) SCL- 90, handleiding bij multidimensionele psychopathologie-indicator. Swets & Zeitlinger BV, Amsterdam
6. Association Française contre les Myopathies (AFM) (1998) La monographie Myoline 'dystrophie musculaire facio-scapulo-humérale'. Evry Cedex
7. Beck AT, Guth D, Steer RA, Ball R (1997) Screening for major depression disorders in medical inpatients with the Beck Depression Inventory for Primary Care. Behav Res Ther 35:785-791
8. Bergner M, Bobbit RA, Carter WB, Gilson BS (1981) The Sickness Impact Scale: development and final revision of a health status measure. Med Care 19:787-805
9. Brouwer OF, Padberg GW, van der Ploeg RJ, Ruys CJ, Brand R (1992) The influence of handedness on the distribution of muscular weakness of the arm in facioscapulohumeral muscular dystrophy. Brain 115:1587-1598
10. Bushby KMD, Pollitt C, Johnson MA, Rogers MT, Chinnery PF (1998) Muscle pain as a prominent feature of facioscapulohumeral muscular dystrophy (FSHD): four illustrative case reports. Neuromuscul Disord 8:574-579
11. Caruso JF, Signorile JF, Perry AC, et al. (1995) The effects of albuterol and isokinetic exercise on the quadriceps muscle group. Med Sci Sports Exerc 27:1471-1476
12. Chaudhuri A, Behan PO (2004) Fatigue in neurological disorders Lancet 363:978-988
13. Dittner AJ, Wessely SC, Brown RG (2004) The assessment of fatigue, a practical guide for clinicians and researchers. J Psychosom Res 56:157- 170
14. Dupont-Versteegden EE (1996) Exercise and clenbuterol as strategies to decrease the progression of muscular dystrophy in mdx mice. J Appl Physiol 80:734-741
15. Häkkinen K (1994) Neuromuscular adaption during strength training, aging, detraining, and immobilization. Crit Rev Phys Rehabil Med 6:161-198
16. Hayes A, Williams DA (1997) Contractile properties of clenbuterol-treated mdx muscle are enhanced by lowintensity swimming. J Appl Physiol 82:435-439
17. Jacobs HM, Lutik A, Touw-Otten FWMM, de Melker RA (1990) [The sickness impact profile; results of an evaluation study of the Dutch version]. Ned Tijdschr Geneeskd 134:1950-1954
18. Johnson EW, Braddom R (1971) Overwork weakness in facioscapulohumeral muscular dystrophy. Arch Phys Med Rehabil 52:333-336
19. Kalkman JS, Schillings ML, van der Werf SP, et al. (2005) Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy and HMSN-I patients. J Neurol Neurosurg Psychiatry 76:1406-1409
20. Kissel JT, McDermott MP, Natarajan R, et al. (1998) Pilot trial of albuterol in facioscapulohumeral muscular dystrophy. FSH-DY Group. Neurology 50:1402-1406
21. Kissel JT, McDermott MP, Mendell JR, et al. (2001) Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy. Neurology 57:1434-1440
22. Koetsier CP (1997) [Pain related to FSH dystrophy. An underestimated problem? Results of an inquiry in the Netherlands]. Dutch Public Fund for Neuromuscular Disorders (VSN). Baarn
23. Krupp LB (2003) Fatigue. Butterworth Heinemann, Philadelphia
24. Lindeman E, Drukker J (1994) Speci- ficity of strength training in neuromuscular disorders. J Rehabil Sci 7:13-15
25. McCartney N, Moroz D, Garner SH, McComas AJ (1988) The effects of strength training in patients with selected neuromuscular disorders. Med Sci Sports Exerc 20:362-368
26. McDonalds CM (2002) Physical activity, health impairments, and disability in neuromuscular disease. Am J Phys Med Rehabil 81:S108-S120
27. Melzack R (1975) The McGill Pain Questionnaire: major properties and scoring methods. Pain 1:277-299
28. Milner-Brown HS, Miller RG (1988) Muscle strengthening through highresistance weight training in patients with neuromuscular disorders. Arch Phys Med Rehabil 69:14-19
29. Olsen DB, Orngreen MC, Vissing J (2005) Aerobic training improves exercise performance in facioscapulohumeral muscular dystrophy. Neurology 64:1064-1066
30. Padberg GW (1982) Facioscapulohumeral disease [thesis]. Leiden University, Leiden
31. Prins JB, Bleijenberg G, Bazelmans E, et al. (2001) Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial. Lancet 357:841-847
32. Tawil R, McDermott MP, Pandya S, et al. (1997) A pilot trial of prednisone in facioscapulohumeral muscular dystrophy. FSH-DY Group. Neurology 48:46-49
33. Vanderiet K, Adriaensen H, Carton H, Vertommen H (1987) The McGill Pain Questionnaire constructed for the Dutch language (MPQ-DV). Preliminary data concerning reliability and validity. Pain 30:395-408
34. van der Kloot WA, Oostendorp RA, van der Meij J, van den Heuvel J (1995) [The Dutch version of the McGill pain questionnaire: a reliable pain questionnaire]. Ned Tijdschr Geneeskd 139:669-673
35. van der Kooi EL, Vogels OJ, van Asseldonk RJ, et al. (2004) Strength training and albuterol in facioscapulohumeral muscular dystrophy. Neurology 63:702-708
36. van Deutekom JC, Wijmenga C, van Tienhoven EA, et al. (1993) FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Hum Mol Genet 2:2037-2042
37. Vercoulen JH, Swanink CM, Fennis JF, Galama JM, van der Meer JW, Bleijenberg G (1994) Dimensional assessment of chronic fatigue syndrome. J Psychosom Res 38:383-392
38. Vercoulen JH, Alberts M, Bleijenberg G (1999) [The Checklist Individual Strength (CIS)]. Gedragstherapie 32:131-136
39. Vignos PJ Jr, Watkins MP (1966) The effect of exercise in muscular dystrophy. JAMA 197:843-848
40. Whooley MA, Simon GE (2000) Managing depression in medical outpatients. N Engl J Med 343:1942-1950
41. Wijmenga C, Hewitt JE, Sandkuijl LA, et al. (1992) Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat Genet 2:26-30
42. Wineski LE, von Deutsch DA, Abukhalaf IK, Pitts SA, Potter DE, Paulsen DF (2002) Muscle-specific effects of hindlimb suspension and clenbuterol in mature male rats. Cells Tissues Organs 171:188-198
43. Yang YT, McElligott MA (1989) Multiple actions of beta-adrenergic agonists on skeletal muscle and adipose tissue. Biochem J 261:1-10